Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial

por Zhao, Yong, Jiang, Zhaoshun, Zhao, Tingbao, Ye, Mingliang, Hu, Chengjin, Zhou, Huimin, Yin, Zhaohui, Chen, Yana, Zhang, Ye, Wang, Shanfeng, Shen, Jie, Thaker, Hatim, Jain, Summit, Li, Yunxiang, Diao, Yalin, Chen, Yingjian, Sun, Xiaoming, Fisk, Mary Beth, Li, Heng
Publicado 2013